Related Experiment Video
Updated: Jul 26, 2025

10:50
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
14.7K
Real-time detection of mAb aggregates in an integrated downstream process
Mariana N São Pedro1, Madelène Isaksson2, Joaquín Gomis-Fons2
1Department of Biotechnology, Delft University of Technology, Delft, The Netherlands.
Biotechnology and Bioengineering
|June 13, 2023
Summary
A miniaturized sensor using fluorescent dyes detects protein aggregation in biopharmaceutical manufacturing. This process analytical technology (PAT) enables faster, real-time monitoring for improved continuous processing and quality control.
Area of Science:
- Biopharmaceutical Manufacturing
- Process Analytical Technology (PAT)
- Microfluidics
Background:
- Continuous processing in biopharma requires real-time monitoring tools.
- Protein aggregation is a critical quality attribute that needs accurate measurement.
- Miniaturized sensors offer faster analysis and quicker decision-making.
Purpose of the Study:
- To integrate and assess a miniaturized fluorescent dye-based sensor in a continuous downstream bioprocess.
- To evaluate the sensor's capability for real-time detection of monoclonal antibody (mAb) aggregation.
- To demonstrate improved process understanding and control through at-line PAT implementation.
Main Methods:
- A microfluidic micromixer utilizing fluorescent dyes (Bis-ANS, CCVJ) was employed.
- The sensor was integrated into a lab-scale ÄKTA™ continuous downstream purification system.
- Viral inactivation and polishing steps were reproduced, with samples analyzed by the sensor post-processing.
Main Results:
- The sensor successfully detected protein aggregation levels as low as 2.5%.
- At-line measurements were completed in under 10 minutes, providing rapid feedback.
- Integration into the continuous process allowed for real-time monitoring of aggregation during purification.
Conclusions:
- The miniaturized PAT tool enables fast, at-line aggregation detection in continuous biopharmaceutical manufacturing.
- This technology enhances process understanding and facilitates better control over product quality.
- The developed system represents a significant step towards implementing robust PAT for continuous bioprocessing.

